| Literature DB >> 9197534 |
M Takano1, H Aida, I Tsuneki, K Takakuwa, I Hasegawa, H Tanaka, M Saito, S Tsuji, T Sonoda, M Hatae, J T Chen, K Takahashi, K Hasegawa, N Toyoda, N Saito, M Yakushiji, T Araki, K Tanaka.
Abstract
We analyzed the alteration of BRCA1 in DNA obtained from 83 individuals of 13 Japanese site-specific ovarian cancer families and 6 breast-ovarian cancer families. Six germline mutations were detected in 7 families, which consisted of 4 breast-ovarian cancer and 3 site-specific ovarian cancer families, by single-strand conformation polymorphism analysis, followed by direct sequence determination. The mutations included three frameshifts, two nonsense mutations, and one missense mutation causing loss of a zinc-binding motif. The frequency of loss of heterozygosity at the microsatellite markers on the BRCA1 gene was 57% (8 of 14 cases) in site-specific ovarian cancer families, and 100% (6 of 6 cases) in breast-ovarian cancer families. All tumors of the patients carrying a mutation of BRCA1 showed deletion of wild-type alleles, implicating BRCA1 as a tumor suppressor gene. These results suggest that germline mutations of the BRCA1 gene play an important role in the carcinogenesis of breast and/or ovarian cancer in a majority of breast-ovarian cancer families and in some site-specific ovarian cancer families.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9197534 PMCID: PMC5921420 DOI: 10.1111/j.1349-7006.1997.tb00397.x
Source DB: PubMed Journal: Jpn J Cancer Res ISSN: 0910-5050